
    
      All adult bone marrow transplant recipients admitted to Asan Medical Center will be enrolled.

      Quantiferon-Gold In-Tube assay will be performed.

      Isoniazid prophylaxis will be given only to patients with clinical risk factors (i.e. recent
      contact with active pulmonary TB patient or inadequate treatment history with abnormal CXR).
      However, isoniazid prophylaxis will be not given based on positive TST or positive
      Quantiferon-Gold In-Tube assay.
    
  